Study of liver cirrhosis over ten consecutive years in Southern China
- PMID: 25309085
- PMCID: PMC4188906
- DOI: 10.3748/wjg.v20.i37.13546
Study of liver cirrhosis over ten consecutive years in Southern China
Abstract
Aim: To investigate the etiology and complications of liver cirrhosis (LC) in Southern China.
Methods: In this retrospective, cross-sectional study, we identified cases of liver cirrhosis admitted between January 2001 to December 2010 and reviewed the medical records. Patient demographics, etiologies and complications were collected, and etiological changes were illustrated by consecutive years and within two time periods (2001-2005 and 2006-2010). All results were expressed as the mean ± SD or as a percentage. The χ(2) test or Student's t-test was used to analyze the differences in age, gender, and etiological distribution, and one-way analysis of variance was applied to estimate the trends in etiological changes. We analyzed the relationship between the etiologies and complications using unconditioned logistic regression, and the risk of upper gastrointestinal bleeding (UGIB) and hepatocellular carcinoma (HCC) in the major etiological groups was evaluated as ORs. A P value less than 0.05 was considered significant. Statistical computation was performed using SPSS 17.0 software.
Results: In this study, we identified 6719 (83.16%) male patients and 1361 (16.84%) female patients. The average age of all of the patients was 50.5 years at the time of diagnosis. The distribution of etiological agents was as follows: viral hepatitis, 80.62% [hepatitis B virus (HBV) 77.22%, hepatitis C virus (HCV) 2.80%, (HBV + HCV) 0.58%]; alcohol, 5.68%; mixed etiology, 4.95%; cryptogenic, 2.93%; and autoimmune hepatitis, 2.03%; whereas the other included etiologies accounted for less than 4% of the total. Infantile hepatitis syndrome LC patients were the youngest (2.5 years of age), followed by the metabolic LC group (27.2 years of age). Viral hepatitis, alcohol, and mixed etiology were more prevalent in the male group, whereas autoimmune diseases, cryptogenic cirrhosis, and metabolic diseases were more prevalent in the female group. When comparing the etiological distribution in 2001-2005 with that in 2006-2010, the proportion of viral hepatitis decreased from 84.7% to 78.3% (P < 0.001), and the proportion of HBV-induced LC also decreased from 81.9% to 74.6% (P < 0.001). The incidence of mixed etiology, cryptogenic cirrhosis, and autoimmune diseases increased by 3.1% (P < 0.001), 0.5% (P = 0.158), and 1.3% (P < 0.001), respectively. Alcohol-induced LC remained relatively steady over the 10-year period. The ORs of the development of UGIB between HBV and other major etiologies were as follows: HCV, 1.07; alcohol, 1.89; autoimmune, 0.90; mixed etiology, 0.83; and cryptogenic, 1.76. The ORs of the occurrence of HCC between HBV and other major etiologies were as follows: HCV, 0.54; alcohol, 0.16; autoimmune, 0.05; mixed etiology, 0.58; and cryptogenic, 0.60.
Conclusion: The major etiology of liver cirrhosis in Southern China is viral hepatitis. However, the proportions of viral hepatitis and HBV are gradually decreasing. Alcoholic LC patients exhibit a greater risk of experiencing UGIB, and HBV LC patients may have a greater risk of HCC.
Keywords: Complication; Epidemiology; Etiology; Hepatocellular carcinoma; Liver cirrhosis; Southern China.
Figures



Similar articles
-
[A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].Korean J Gastroenterol. 2007 Jun;49(6):369-75. Korean J Gastroenterol. 2007. PMID: 17641555 Korean.
-
Study of liver cirrhosis over twenty consecutive years in adults in Southern China.World J Hepatol. 2023 Dec 27;15(12):1294-1306. doi: 10.4254/wjh.v15.i12.1294. World J Hepatol. 2023. PMID: 38223413 Free PMC article.
-
Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China.J Med Virol. 2024 Jan;96(1):e29405. doi: 10.1002/jmv.29405. J Med Virol. 2024. PMID: 38235623
-
Hepatocellular carcinoma in cirrhosis: incidence and risk factors.Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. doi: 10.1053/j.gastro.2004.09.014. Gastroenterology. 2004. PMID: 15508101 Review.
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
Cited by
-
The association of chronic liver disorders with exacerbation of symptoms and complications related to COVID-19: A systematic review and meta-analysis of cohort studies.Clin Respir J. 2022 Dec;16(12):777-792. doi: 10.1111/crj.13552. Epub 2022 Oct 18. Clin Respir J. 2022. PMID: 36254683 Free PMC article.
-
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.J Gastroenterol. 2020 Mar;55(3):353-362. doi: 10.1007/s00535-019-01645-y. Epub 2019 Nov 25. J Gastroenterol. 2020. PMID: 31768801 Free PMC article.
-
ICG-r15 predicts esophageal varices in compensated liver cirrhosis: a noninvasive approach.BMC Gastroenterol. 2024 Nov 1;24(1):390. doi: 10.1186/s12876-024-03407-4. BMC Gastroenterol. 2024. PMID: 39487442 Free PMC article.
-
Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B.Int J Gen Med. 2024 Jun 25;17:2877-2886. doi: 10.2147/IJGM.S464083. eCollection 2024. Int J Gen Med. 2024. PMID: 38947567 Free PMC article.
-
miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.J Biomed Sci. 2016 Nov 10;23(1):79. doi: 10.1186/s12929-016-0295-7. J Biomed Sci. 2016. PMID: 27832779 Free PMC article.
References
-
- Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–538. - PubMed
-
- Seeff LB, Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene. 2006;25:3771–3777. - PubMed
-
- Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45:86–94. - PubMed
-
- Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. J Hepatol. 2008;49:732–738. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical